Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytek Biosciences (CTKB)
NASDAQ:CTKB
Cytek Biosciences (CTKB) Ownership Overview
9.22% Insiders
16.83% Mutual Funds
13.86% Other Institutional Investors
22.10% ETFs
38.00% Public Companies and Individual Investors
The ownership structure of Cytek Biosciences (CTKB) stock is a mix of institutional, retail, and individual investors. Approximately 52.79% of the company’s stock is owned by Institutional Investors, 9.22% is owned by Insiders, and 38.00% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,670,169 | Institution | 10.61% | 71,494,984 | |
| 10,686,046 | Institution | 8.30% | 55,888,021 | |
| 9,103,128 | Institution | 7.07% | 47,609,359 | |
| 6,809,404 | Institution | 5.29% | 35,613,183 | |
| 6,203,867 | Insider | 4.70% | 32,446,224 | |
| 5,702,130 | Insider | 4.30% | 29,822,140 | |
| 3,464,590 | Institution | 2.69% | 18,119,806 | |
| 1,893,923 | Institution | 1.47% | 9,905,217 | |
| 1,381,341 | Institution | 1.07% | 7,224,413 | |
| 1,059,008 | Institution | 0.82% | 5,538,612 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,103,128 | Institution | 7.07% | 47,609,359 | |
| 3,464,590 | Institution | 2.69% | 18,119,806 | |
| 1,381,341 | Institution | 1.07% | 7,224,413 | |
| 1,059,008 | Institution | 0.82% | 5,538,612 | |
| 795,884 | Institution | 0.62% | 4,162,473 | |
| 729,834 | Institution | 0.57% | 3,817,032 | |
| 663,807 | Institution | 0.52% | 3,471,711 | |
| 605,656 | Institution | 0.47% | 3,167,581 | |
| 516,625 | Institution | 0.40% | 2,701,949 | |
| 383,630 | Institution | 0.30% | 2,006,385 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,679,410 | Institution | 5.19% | 34,866,520 | |
| 3,366,975 | Institution | 2.61% | 21,851,668 | |
| 3,251,879 | Institution | 2.52% | 17,007,327 | |
| 2,624,273 | Institution | 2.04% | 17,031,532 | |
| 1,582,369 | Institution | 1.23% | 10,269,575 | |
| 1,483,079 | Institution | 1.15% | 9,625,183 | |
| 1,185,323 | Institution | 0.92% | 6,187,386 | |
| 1,123,132 | Institution | 0.87% | 5,873,980 | |
| 939,738 | Institution | 0.73% | 4,905,432 | |
| 728,959 | Institution | 0.57% | 3,812,456 |
FAQ
Who Owns Cytek Biosciences (CTKB)?
According to the latest TipRanks data, approximately 13.86% of the company's stock is held by institutional investors, 9.22% is held by insiders, and 38.00% is held by retail investors.
What percentage of Cytek Biosciences (CTKB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.86% of Cytek Biosciences (CTKB) stock is held by institutional investors.
What percentage of Cytek Biosciences (CTKB) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.00% of Cytek Biosciences (CTKB) stock is held by retail investors.
Who owns the most shares of Cytek Biosciences (CTKB)?
iShares owns the most shares of Cytek Biosciences (CTKB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.